Literature DB >> 11020394

Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.

M J Fine1, H M Pratt, D S Obrosky, J R Lave, L J McIntosh, D E Singer, C M Coley, W N Kapoor.   

Abstract

PURPOSE: Patients with pneumonia often remain hospitalized after becoming clinically stable, without demonstrated benefits on outcome. The purposes of this study were to assess the relation between length of hospital stay and daily medical care costs and to estimate the potential cost savings associated with a reduced length of stay for patients with pneumonia. SUBJECTS AND METHODS: As part of a prospective study of adults hospitalized with community-acquired pneumonia at a community hospital and two university teaching hospitals, daily medical care costs were estimated by multiplying individual charges by department-specific cost-to-charge ratios obtained from each hospital's Medicare cost reports.
RESULTS: The median total cost of hospitalization for all 982 inpatients was $5, 942, with a median daily cost of $836, including $491 (59%) for room and $345 (41%) for non-room costs. Average daily non-room costs were 282% greater on the first hospital day, 59% greater on the second day, and 19% greater on the third day than the average daily cost throughout the hospitalization (all P <0.05), and were 14% to 72% lower on the last 3 days of hospitalization. Average daily room costs remained relatively constant throughout the hospital stay, with the exception of the day of discharge. A projected mean savings of $680 was associated with a 1-day reduction in length of stay.
CONCLUSIONS: Despite institutional differences in total costs, patterns of daily resource use throughout hospitalization were similar at all institutions. A 1-day reduction in length of stay might yield substantial cost-savings.

Entities:  

Mesh:

Year:  2000        PMID: 11020394     DOI: 10.1016/s0002-9343(00)00500-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

Review 1.  Economic aspects of pneumococcal pneumonia: a review of the literature.

Authors:  Diana De Graeve; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

3.  Factors associated with length of stay in hospital for suspected community-acquired pneumonia.

Authors:  Jane Q Huang; Peter M Hooper; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

4.  Effects of Including Variables Such as Length of Stay in a Propensity Score Analysis With Costs as Outcome.

Authors:  Vagish Hemmige; Michael Z David
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

5.  Hospital Treatment Costs and Factors Affecting These Costs in Community-Acquired Pneumonia.

Authors:  Fatma Tokgöz Akyıl; Armağan Hazar; İpek Erdem; Canan Pehlivan Öneş; Murat Yalçınsoy; İlim Irmak; Umut Sabri Kasapoğlu
Journal:  Turk Thorac J       Date:  2015-07-01

Review 6.  Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?

Authors:  Friedrich Vogel
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  The effect of English language proficiency on length of stay and in-hospital mortality.

Authors:  Ava John-Baptiste; Gary Naglie; George Tomlinson; Shabbir M H Alibhai; Edward Etchells; Angela Cheung; Moira Kapral; Wayne L Gold; Howard Abrams; Maria Bacchus; Murray Krahn
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

Review 8.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Pilot Study on Early Postoperative Discharge in Pituitary Adenoma Patients: Effect of Socioeconomic Factors and Benefit of Specialized Pituitary Centers.

Authors:  Christopher A Sarkiss; James Lee; Joseph A Papin; Eliza B Geer; Rudrani Banik; Janet C Rucker; Barbara Oudheusden; Satish Govindaraj; Raj K Shrivastava
Journal:  J Neurol Surg B Skull Base       Date:  2015-04-27

10.  Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.

Authors:  Jeremy J Moeller; Martin Ma; Paul Hernandez; Thomas Marrie; Claire Touchie; Ward Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.